Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 96 of the 97 references it cites were found in a registry or an index; 20 of the 98 sources its claims cite were checked for support.

Light therapy for bipolar disorders: Clinical recommendations from the international society for bipolar disorders (ISBD) Chronobiology and Chronotherapy Task Force

Open access

Abstract

The International Society for Bipolar Disorders (ISBD) Chronobiology and Chronotherapy Task Force conducted a comprehensive review to deliver concise evidence-based recommendations on the use of bright light therapy (BLT) for bipolar disorder (BD). Adjunctive BLT is likely an efficacious acute treatment for bipolar depression as implicated by higher quality evidence. The position of maintenance BLT for relapse prevention awaits further investigation. Protocols of effective BLT in BD are similar to parameters indicated for treatment of seasonal and non-seasonal major depressive disorder. Anti-manic prophylaxis (especially for BD-I) and clinical monitoring are recommended with initiation of and ongoing light treatment. Administer BLT daily, preferably in the morning or at mid-day. If mornings are prohibitive, then mid-day exposure, implemented to avoid excessively early wake times, is an acceptable alternative. Informed by the literature, target 30 min/day of BLT exposure. Patients wary of emergent hypomania or partial responders, can initiate 15 min/day and increase by 15 min each week to full response (or 30-60 min/day by the fourth week). Consider patient centred outcome assessments to evaluate mood response, safety and side effects. Clinical improvement is typically observed within 1-2 weeks, with response/remission expected by 4-6 weeks. Integration of BLT with other chronotherapeutic strategies may enhance long-term efficacy.

Overview

CoChat Summary

TL;DR

This ISBD Task Force evidence-based practice guideline concludes adjunctive bright light therapy (BLT) is likely efficacious for acute bipolar depression, with protocols similar to those used in seasonal and non-seasonal major depressive disorder. It provides step-by-step clinical recommendations on dosing, timing, safety monitoring, anti-manic prophylaxis, and implementation, while noting that maintenance evidence and long-term RCTs in bipolar disorder are lacking.

Key findings

  • Adjunctive BLT is likely an efficacious acute treatment for bipolar depression. In meta-analyses cited, Lam et al. found significant improvement in clinician-rated depressive symptoms (HDRS SMD = 0.43; p = 0.03) and clinical response favouring BLT (OR = 2.32; p = 0.024); Geoffroy et al. found combination BLT plus antidepressant superior to monotherapy (SMD = 0.56; p < 0.001), with no significant difference between BLT and drug alone (SMD = 0.19; p = 0.17).
  • Recommended acute protocol: bright, white, UV-filtered light at 5,000–10,000 lux, 30–33 cm from the eyes; daily morning (7:00–9:00 AM) or mid-day (12:00–2:30 PM) exposure; target 30 min/day, with an option to start at 15 min/day and increase by 15 min weekly to 30–60 min/day by week 4. Clinical improvement is typically seen within 1–2 weeks, with response/remission expected by 4–6 weeks.
  • Anti-manic prophylaxis is recommended especially for BD-I, with an adequate mood stabiliser for at least 2–4 weeks before initiating BLT and during treatment. In the LuBi trial cited, 2/34 participants (6%) experienced a hypomanic switch, 5/34 (15%) had subsyndromic hypomanic symptoms, and overall 7/34 (20.6%) exhibited either subsyndromic or full-blown hypomania; all symptoms resolved within 3 days after dose reduction.
  • Maintenance BLT for relapse prevention awaits further investigation. The paper notes no longer-term follow-up RCTs of BLT in BD; expert consensus recommends continuing BLT until full episode recovery and maintaining for 1 year, with many patients possibly able to reduce intensity or duration.

Methods

  • Design: ISBD Chronobiology and Chronotherapy Task Force comprehensive review and evidence-based practice guideline, including a brief narrative review of efficacy studies and clinical recommendations.
  • Data: published literature on BLT in bipolar disorder, major depressive disorder, and seasonal affective disorder, including RCTs and meta-analyses; the LuBi dose-escalation phase 1/2 randomised double-blind trial (n = 34) is cited for hypomanic switch rates. No new primary data were collected.
  • Analysis: narrative synthesis and consensus recommendations, with protocol tables (Tables 1–2) and a clinical algorithm.

Limitations

  • The paper states that varying light treatment parameters, small sample sizes, brief durations of therapy, and inconsistent quality across trials may limit generalisability; maintenance BLT for relapse prevention awaits further investigation, and there are no longer-term follow-up RCTs of BLT in BD.
  • The paper states that LuBi observations were limited by sample size, that there is a disproportionate lack of human data from light studies, and that feasibility/implementation barriers include cost, lack of reimbursement, suboptimal adherence, device standardisation, and access issues in low- and middle-income countries.
  • Evident from the text: many recommendations rely on expert consensus and indirect evidence from SAD/MDD, and some parameters—such as optimal timing and light source spectra for non-seasonal bipolar depression—are not fully standardised.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1080/19585969.2025.2533806

Cites

96 of 96 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. Pathways of bright light therapy (Courtesy of P. Ritter).
Figure 1. Pathways of bright light therapy (Courtesy of P. Ritter).CC BY · PubMed Central
Figure 2. Clinical algorithm: Bright light therapy in bipolar disorder.
Figure 2. Clinical algorithm: Bright light therapy in bipolar disorder.CC BY · PubMed Central
Figure 3. Proper placement of an example of bright light box. (Courtesy of Jessica Rao, www.cet.org).
Figure 3. Proper placement of an example of bright light box. (Courtesy of Jessica Rao, www.cet.org).CC BY · PubMed Central

Verification

Claims the paper makes

17 Valid · 1 Not valid · 47 Not checked · 14 Own results and interpretations

42 more claims · 4 with their cited sources checked

Create a free account to see all 79 claims and to verify the 3 references still open.

See all claims — free account
  • Probably not a substantial claim. 8
  • It may state two separate claims as one. 28

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 97 references

Research works printed but not linked: 2

  1. 10.1111/bdi.13018 · DOI · Paper page
  2. Williams JBW, Terman M. 2003. Structured interview guide for the Hamilton Depression Rating Scale with atypical depression supplement (SIGH-ADS). New York NY: New York State Psychiatric Institute.

Cited by

See all 10

Metadata

Authors
Geoffroy, P. A., Palagini, L., Henriksen, T. E. G., Bourgin, P., Garbazza, C., Gronfier, C., Esaki, Y., Fernandez, D. C., Lam, R. W., Lee, H.-J., Lejoyeux, M., Maruani, J., Martiny, K., Murray, G., Riemersma-Van Der Lek, R. F., Ritter, P., Schulte, P. F. J., Smith, D. J., Terman, M., Zeitzer, J. M., & Sit, D. K.
Affiliations
  • Centre National de la Recherche Scientifique (FR)
  • University of Pisa (IT)
  • Fonna Hospital Trust (NO)
  • Universitäre Psychiatrische Kliniken Basel (CH)
  • Lyon 1 Université (FR)
  • Fujita Health University (JP)
  • Cincinnati Children's Hospital Medical Center (US)
  • University of British Columbia (CA)
  • Korea University (KR)
  • Inserm (FR)
  • University of Copenhagen (DK)
  • Swinburne University of Technology (AU)
  • Mental Health Services Drenthe
  • University Hospital Carl Gustav Carus (DE)
  • GGZ Noord-Holland-Noord (NL)
  • University of Edinburgh (GB)
  • Columbia University (US)
  • Stanford Medicine (US)
  • Northwestern University (US)
Corresponding author
Geoffroy, Pierre A.
Venue
Dialogues in Clinical Neuroscience
Published
2025-07-24
Volume
27
Issue
1
Pages
249-264
ISSN
  • 1294-8322 (ISSN-L)
  • 1958-5969
OpenAlex
W4412623193
Cited by
10
References
97
Citations by year
2026: 9 · 2025: 1
FWCI
1.77
Type
journal article
Language
en
Open access
Locations
  • Dialogues in Clinical Neuroscience (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
  • HAL (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
bright light therapy, bipolar disorder, bipolar depression, chronotherapy, chronobiology, relapse prevention, treatment response and remission, adjunctive therapy
MeSH terms
Bipolar Disorder, Chronobiology Phenomena, Circadian Rhythm, Humans, Phototherapy, Societies, Medical, Chronotherapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Light therapy for bipolar disorders: Clinical recommendations from the international society for bipolar disorders (ISBD) Chronobiology and Chronotherapy Task Force. https://app.cochat.ai/papers/10.1080/19585969.2025.2533806
The paper
Geoffroy, P. A., Palagini, L., Henriksen, T. E. G., Bourgin, P., Garbazza, C., Gronfier, C., Esaki, Y., Fernandez, D. C., Lam, R. W., Lee, H.-J., Lejoyeux, M., Maruani, J., Martiny, K., Murray, G., Riemersma-Van Der Lek, R. F., Ritter, P., Schulte, P. F. J., Smith, D. J., Terman, M., . . . Sit, D. K. (2025). Light therapy for bipolar disorders: Clinical recommendations from the international society for bipolar disorders (ISBD) Chronobiology and Chronotherapy Task Force. Dialogues in Clinical Neuroscience. https://doi.org/10.1080/19585969.2025.2533806

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.